Hansa Biopharma treats first commercial kidney transplant patient in Australia with Idefirix
Hansa Biopharma (HNSA) announces its first commercial kidney transplant patient treated with Idefirix in Australia.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.